KBank and Ant International Partner on Cross-Border Payments and Liquidity Management in Thailand
29.5.2026 06:00:00 EEST | Business Wire | Press release
KASIKORNBANK (KBank) and Ant International have formed a strategic collaboration to jointly develop an integrated financial infrastructure to deliver faster, more reliable, and scalable payment experiences for Ant International and its customers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260528577525/en/
Kelvin Li, General Manager of Platform Tech and Senior Vice President at Ant International (Left) and Dr. Karin Boonlertvanich, Executive Vice President of KASIKORNBANK (Right) at the MOU Signing Ceremony
The Memorandum of Understanding (MoU) will combine KBank’s regulated financial capabilities with Ant International’s financial AI solutions to enable real-time, 24/71 cross-border USD transactions. The initiative will leverage Blockchain Deposit Accounts from Kinexys by J.P. Morgan, the industry-leading blockchain business part of J.P. Morgan Payments for real-time USD liquidity movement and is expected to significantly enhance transaction speed while enabling continuous 24/72 operations. KBank and Ant International will also use their best efforts to develop end-to-end solutions across payment acceptance, clearing, and settlement. These advancements remain subject to all necessary legal and regulatory approvals.
This collaboration will enhance Ant International’s inbound and outbound transaction and settlement efficiency, thus improving the business cashflow of the merchants the company serves.
This partnership builds on KBank’s existing collaboration with Ant International’s global payment services. Through Alipay+, Ant International’s digital wallet gateway, KBank’s mobile banking app KPLUS is connected into an ecosystem of 150 million merchants and 1.8 billion consumer accounts worldwide. KPLUS is also a growing payment option on Google Pay for Thai merchants through its integration with Antom, Ant International’s merchant payment service.
Dr. Karin Boonlertvanich, Executive Vice President of KASIKORNBANK, said, “This collaboration addresses a fundamental limitation in today’s cross-border financial systems, where liquidity movement remains constrained by fragmented infrastructure. By integrating blockchain with regulated financial systems, we are enabling a more continuous, transparent, and scalable flow of funds between global networks and local economies.”
Kelvin Li, General Manager of Platform Tech and Senior Vice President at Ant International, said, “Across emerging markets, industry leaders like KBank are preparing communities for a more interconnected global economy with broader and more secure application of AI and blockchain technology. We are thrilled to support KBank with such fintech solutions to empower Thai merchants – especially small businesses – with more efficient payment tools to thrive globally.”
This MOU underscores a shared commitment to the development of integrated and scalable cross-border financial systems, enhancing the efficiency and reliability of global payment systems for international commerce.
The development and potential implementation of this initiative will be undertaken in consultation with the relevant regulatory authorities, and will be subject to obtaining the necessary approvals prior to any live service deployment.
About KASIKORNBANK
KASIKORNBANK PUBLIC COMPANY LIMITED (KBank) operates under the vision of being a “Bank of Sustainability”, dedicated to delivering long-term value to all stakeholders through innovation, strong governance, and responsible growth. KBank continues to strengthen its leadership in digital banking through strategic initiatives that drive financial inclusion and cross-border interoperability, including the development of blockchain-based infrastructure and regulated on-chain payment ecosystems in partnership with global innovators.
About Ant International
Ant International is a leading global digital payment, digitisation and financial technology provider. Through collaboration across the private and public sectors, our unified techfin platform supports financial institutions and merchants of all sizes to achieve inclusive growth through a comprehensive range of cutting-edge digital payment and financial services solutions. To learn more, please visit https://www.ant-intl.com/
| 1 Transfers on the network are completed on a 24/7/365 and same day basis. Moving funds to and from the network from traditional Demand Deposit Accounts on legacy systems to Blockchain Deposit Accounts has a three- hour downtime over the weekend (3-6 p.m. EST every Saturday.) Enhancement is under development. | |
| 2 Transfers on the network are completed on a 24/7/365 and same day basis. Moving funds to and from the network from traditional Demand Deposit Accounts on legacy systems to Blockchain Deposit Accounts has a three- hour downtime over the weekend (3-6 p.m. EST every Saturday.) Enhancement is under development. | |
View source version on businesswire.com: https://www.businesswire.com/news/home/20260528577525/en/
Contacts
Media Contact
KASIKORNBANK
kbankpr@kasikornbank.com
Ant International
Global Communications
pr@ant-intl.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 15:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.
Fortegra Completes Acquisition by DB Insurance29.5.2026 23:30:00 EEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 23:01:00 EEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom